Join
Live feed
·
INSIDERFilingvia Quantisnow
Senti Biosciences Inc. logo

Pres. & Chief Med. & Dev. Off. Rajangam Kanya sold $6,074 worth of shares (1,479 units at $4.11), decreasing direct ownership by 15% to 8,621 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SNTI· Senti Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNTI (Senti Biosciences Inc.) and more on Quantisnow.